PT3298139T - Método para reduzir ou inativar o conteúdo viral e microbiano nos processos de fabrico de pancreatina - Google Patents
Método para reduzir ou inativar o conteúdo viral e microbiano nos processos de fabrico de pancreatinaInfo
- Publication number
- PT3298139T PT3298139T PT167973189T PT16797318T PT3298139T PT 3298139 T PT3298139 T PT 3298139T PT 167973189 T PT167973189 T PT 167973189T PT 16797318 T PT16797318 T PT 16797318T PT 3298139 T PT3298139 T PT 3298139T
- Authority
- PT
- Portugal
- Prior art keywords
- pancreatin
- manufacture
- processes
- reducing
- microbial content
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/94—Pancreatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562163779P | 2015-05-19 | 2015-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3298139T true PT3298139T (pt) | 2021-11-05 |
Family
ID=78230867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167973189T PT3298139T (pt) | 2015-05-19 | 2016-05-19 | Método para reduzir ou inativar o conteúdo viral e microbiano nos processos de fabrico de pancreatina |
Country Status (3)
| Country | Link |
|---|---|
| DK (1) | DK3298139T3 (es) |
| ES (1) | ES2896244T3 (es) |
| PT (1) | PT3298139T (es) |
-
2016
- 2016-05-19 PT PT167973189T patent/PT3298139T/pt unknown
- 2016-05-19 ES ES16797318T patent/ES2896244T3/es active Active
- 2016-05-19 DK DK16797318.9T patent/DK3298139T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2896244T3 (es) | 2022-02-24 |
| DK3298139T3 (da) | 2021-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3372484A4 (en) | GAS TREATMENT SYSTEM AND CONTAINER THEREWITH | |
| EP3119532A4 (en) | Treated article and method of making the same | |
| EP3286142A4 (en) | Liquid treatment system and method | |
| EP3166615A4 (en) | Methods for the treatment of hepatitis b and hepatitis d virus infections | |
| EP3270909A4 (en) | Fixed dose combinations comprising etc1002 and one or more statins for treating or reducing cardiovascular risk | |
| IL247938A0 (en) | Onconas for use in the treatment or prevention of viral infections | |
| EP3463324A4 (en) | LEVOCETTIRIZINE AND MONTELUKAST IN THE TREATMENT OF MEDIATED CONDITIONS OF MEDIA BY EXPOSURE TO RADIATION | |
| EP3377085A4 (en) | PEPTIDES AND METHODS FOR TREATING ENDOMETRIOSIS USING THE SAME PEPTIDES | |
| PL3298139T3 (pl) | Sposób zmniejszenia lub inaktywacji zawartości wirusów i drobnoustrojów w sposobach wytwarzania pankreatyny | |
| IL258237B (en) | Treatment of viral conjunctivitis using ranpirinase and/or ampinase | |
| EP3341006A4 (en) | COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE | |
| HK1255695A1 (zh) | 用於治療眼瞼下垂的組合物和方法 | |
| EP3294392A4 (en) | Nebulizers and uses thereof | |
| PL3247651T3 (pl) | Pojemnik ze środkiem do traktowania oraz sposób jego wytwarzania | |
| GB2539474B (en) | Glove and treatment method | |
| PL3658174T3 (pl) | Laktoferycyna i laktoferampina do leczenia infekcji | |
| GB201612612D0 (en) | Computing system and method of operating the computing system | |
| ZA201904328B (en) | Composition, application thereof and treatment method | |
| PT3298139T (pt) | Método para reduzir ou inativar o conteúdo viral e microbiano nos processos de fabrico de pancreatina | |
| IL253418A0 (en) | Nisin-based compounds and their use in the treatment of bacterial infections | |
| GB2558090B (en) | Prevention and treatment for microbial infections | |
| GB201617715D0 (en) | Methods for the treatment and prevention of ebola | |
| IL250272A0 (en) | Enzyme without sugar residue and its uses | |
| IL260410B (en) | Puzzle system and method for it | |
| GB201620551D0 (en) | Enzymes and uses thereof |